Hair loss robot gains FDA approval

April 26, 2011 by Katie Gatto in Medical research weblog

Hair loss robot gains FDA approval

Enlarge

(Medical Xpress) -- Restoration Robotics Inc., a privately-held medical device company which is based in California, has received FDA approval for their ARTAS System. The ARTAS System, which is designed to harvest the hair follicles from the scalp of men who have been diagnosed with androgenetic alopecia, a condition that is more commonly known as male pattern hair loss, in men who also have black or brown straight hair, has received its 510K clearance from the Food & Drug Administration.

The system, which was developed with the help of several leading hair restoration physicians, is designed to enhance the quality of follicular unit harvesting. The system is physician-controlled and completely interactive. The system uses a combines of several different features which include an image-guided robotic arm, some unique imaging technologies, and a set of small dermal punches, and a computer interface which allows the doctor to control these elements. The ARTAS System is able to identify and harvest an individual follicular unit. This is needed to implement a restoration technique called the follicular unit extraction (FUE) technique.

The follicular unit extraction technique is preferable for many patients because it is less invasive and allows the men in question to return to their normal lives with a shorter recovery time. The system preforms the hair restoration as an office-based procedure, which also has the potential to reduce the costs of the procedure. The newly implanted hairs will develop their own blood supply, and gradually begin to grow and new hairs. These new hairs will begin to grow only a few months after the procedure, and continue for up to a full year. This creates a more natural appearance of hair then simply putting on a wig.

• Follow Medical Xpress on Facebook!
• Follow Medical Xpress on Twitter!



More information: www.restorationrob… hnology.html

© 2010 PhysOrg.com

3.1 /5 (9 votes)  

Filter


Move the slider to adjust rank threshold, so that you can hide some of the comments.


Display comments: newest first

bsummey
Apr 26, 2011

Rank: 5 / 5 (1)
What the heck does continue up to a full year mean? The hair is only good for a year. I don't see the value in having a robot beat me in the head one hair at a time for one year of peach fuzz.
jjoensuu
Apr 26, 2011

Rank: not rated yet
It looks like the article was never proofread for typos and bad grammar...
Msean1941
Apr 26, 2011

Rank: not rated yet
It clearly states "The system uses a combines of several different features".
baudrunner
Apr 27, 2011

Rank: 1 / 5 (1)
Remember that this is a Californian company, where people generally have very low self-esteem but are generally very wealthy, too. Just goes to show, most rich people shouldn't even have money.
Rank 3.1 /5 (9 votes)
Relevant PhysicsForums posts

More news stories

A molecular explanation for age-related fertility decline in women

(Medical Xpress)—Scientists supported by the National Institutes of Health have a new theory as to why a woman's fertility declines after her mid-30s. They also suggest an approach that might help slow ...

Medical research created 1 hour ago | popularity not rated yet | comments 0 | with audio podcast

Medical researchers discover new ways to target, develop and design drugs to prevent and treat viral infection

Researchers at the University of Alberta have discovered a new drug target, developed a new drug and identified a new way to design drugs—all of which could be a winning combination in the battle against viruses.

Medical research created 1 hour ago | popularity not rated yet | comments 0 | with audio podcast

Targeting the X-factor to tackle cardiovascular disease

New research at The University of Nottingham aimed at preventing harmful blood clots associated with heart disease and stroke has recently received a major funding boost from the British Heart Foundation.

Medical research created 2 hours ago | popularity not rated yet | comments 0

Italy approves law on controversial stem cell therapy

Italian lawmakers on Wednesday gave their final approval to a law that allows limited use of a controversial type of stem cell therapy which has been condemned by many scientists but has given hope to families of terminally-ill ...

Medical research created 2 hours ago | popularity 5 / 5 (1) | comments 1

H. pylori, smoking trends, and gastric cancer in US men

Trends in Helicobacter pylori (H. pylori) and smoking explain a significant proportion of the decline of intestinal-type noncardia gastric adenocarcinoma (NCGA) incidence in US men between 1978 and 2008, and are estimated ...

Medical research created 16 hours ago | popularity not rated yet | comments 0


Alcohol sales fall due to ban on multi-buy promotions

(Medical Xpress)—A report published today shows a 2.6% decrease in the amount of alcohol sold per adult in Scotland in the year following the introduction of the Alcohol etc. (Scotland) Act in October 2011.

Facing the chill wind of blood pressure

(Medical Xpress)—High blood pressure is something that has traditionally been a problem in Scotland, but might there be a link to our climate?

US health care: Does more spending yield better health?

(Medical Xpress)—Health care spending is much higher for older Americans than for younger adults and children, on average, and analysts have said that increasing spending leads to longer life expectancy.

Study shows low rate of late lumen loss with bioresorbable DESolve device

The DESolve bioresorbable coronary scaffold system achieves good efficacy and safety with low rates of late lumen loss and major coronary adverse events at six months, show first results from the pivotal DESolve Nx trial ...

Study finds COPD is over-diagnosed among uninsured patients

More than 40 percent of patients being treated for COPD at a federally funded clinic did not have the disease, researchers found after evaluating the patients with spirometry, the diagnostic "gold standard" for chronic obstructive ...

Registry questions superiority of bivalirudin over heparin

Results from a large observational study reported at EuroPCR 2013 today question whether bivalirudin is superior to heparin in the absence of GPIIb/IIIa blockade, showing similar 30-day mortality in patients with non-ST segment ...